Canadian Pharmacy Blog

On the basis of positive results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT), Novartis Pharmaceuticals plans to file for a new indication for valsartan (Generic Diovan®). This is the only cardiovascular agent ever shown in a rigorous head-to-head trial to have all of the proven benefits of captopril (Capoten drug, Apothecon), an angiotensin-converting [...]

A tablet made by Novartis combines two agents used to treat hypertension: valsartan (Generic Diovan), an angiotensin-receptor blocker (ARB), and amlodipine (Norvasc tablet), a calcium-channel blocker (CCB). Both drugs allow blood vessels to relax so that blood can flow more easily. The FDA’s approval was supported by a clinical program involving more than 5,000 patients. [...]